This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Mistakes disrupt budgets and derail goals. Explore how small oversights impact finances and how to recalibrate for stable, predictable spending.
27,871 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
The popular image of Annaly Capital focuses on its hefty dividend. But the real investment story sits in the balance ...
Lionsgate faces a pivotal year as it balances streaming momentum with theatrical cycles and debt. This guide breaks d...
Dell stocks jumped ahead this week as rival Lenovo signals hint at broader hardware demand. This guide breaks down wh...
Intel’s 2026 comeback stunned many investors. This article breaks down the core reason behind the rally and what it c...
Saia stock swooned this week after a high-profile downgrade rattled traders, even as some metrics showed resilience. ...
A CFO's $2.1 million sale of OUSTER shares raises questions for investors. This analysis explains what such insider m...
More Americans 65+ continue to work and fund HSAs, but Medicare Part A backdating can create excess contributions and...
A major market moment is shaping up as Dan Ives weighs in on SpaceX’s potential public debut. This article breaks dow...
Healthcare costs keep rising, and the momentum isn’t slowing. This article breaks down the drivers, shows how to inve...
Facing a slide in Micron's stock, investors wonder: why is micron stock still falling? This guide breaks down the mem...
On Thursday, Vertex stock surged nearly 6% after a positive analyst note. This guide breaks down what drove the move,...